Post

Komoh
Komoh
Moderna Q3 Outlook: Moderna (MRNA) is set to report its Q3 results before the US market open on Nov 6, following a net loss of approximately $800M in Q2.  Market Sentiment: Sentiment on the prediction market "Will Moderna (MRNA) beat quarterly earnings?" leans heavily optimistic, with 94% voting "Yes" against 6% for "No" on a volume of 2.61M.  #ModernaQ3VaccineSales

Haftungsausschluss: OKX Orbit-Inhalt dient nur zu Informationszwecken. Mehr erfahren

Antworten

Noch keine Kommentare. Schreib die erste Antwort!